ACE2 and COVID-19: Another theory shows that SARS-CoV-2 disease downregulates ACE2, resulting in decreased activation of the mammalian target of rapamycin (mTOR) and increased autophagy, resulting in intestinal dysbiosis, diarrhea, and other sympotoms[35].